Skip to main content
Clinical Trials/CTRI/2021/10/037093
CTRI/2021/10/037093
Not yet recruiting
未知

A randomised clinical study on the effectiveness of Ketamine vs Placebo in the treatment of bipolar depression

Ahana hospitals LLP0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: F313- Bipolar disorder, current episodedepressed, mild or moderate severityHealth Condition 2: F314- Bipolar disorder, current episodedepressed, severe, without psychotic features
Sponsor
Ahana hospitals LLP
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Written informed consent.
  • Patients diagnosed with bipolar affective disorder current episode depression as per ICD 10 guidelines
  • Patients started on antidepressants specifically SNRIs

Exclusion Criteria

  • Co\-morbid psychiatric diagnoses such
  • as psychosis, substance dependence
  • Mental retardation, neurological disorders, and severe medical illness
  • Pregnancy or breastfeeding
  • Allergy to ketamine

Outcomes

Primary Outcomes

Not specified

Similar Trials